Delirious Patients

Massachusetts General Hospital Handbook of General Hospital Psychiatry

Volumn , Issue , 2004, Pages 119-134

  Cassem, Ned H ^a,b   Murray, George B ^a,b   Lafayette, Jennifer M ^a,b   Stern, Theodore A ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c EMERSON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745211746     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02767-0.50016-4     Document Type: Chapter

References (60)

1. Rincon HG, Granados M, Unutzer J, et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics 2001, 42:391-396.
2. American Psychiatric Association Practice guidelines for the treatment of patients with delirium. Am J Psychiatry 1999, 156(5 Supp):1-20.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders, (DSM-IV) 1994, American Psychiatric Association, Washington, DC. ed 4.
4. Chedru F, Geschwind N Writing disturbances in acute confusional states. Neuropsychologia 1972, 10:343-353.
5. Mesulam M-M, Waxman SG, Geschwind N, et al. Acute confusional state with right middle cerebral artery infarctions. J Neural Neurosurg Psychiatry 1976, 39:84-89.
6. Webster R, Holroyd S Prevalence of psychotic symptoms in delirium. Psychosomatics 2000, 41:519-522.
7. Engle GL, Romano J Delirium, a syndrome of cerebral insufficiency. J Chronic Dis 1959, 9:260-277.
8. Murray GB, Jasper HH The role of mechanisms in the learning of a tactile discrimination in the monkey. Cellular mechanisms of conditioning and behavioral plasticity 1986, University of Washington Press, Seattle. C.D. Woody, D.L. Alkon, J.L. McGaugh (Eds.).
9. Wilder A Pharmacologic dissociation of behavior and EEG "sleep patterns" in dogs: morphine, N-allynormorphine and atropine. Proc Soc Exp Biol Med 1952, 79:261-265.
10. Thierry AM, Tassin JP, Blanc G, et al. Selective activation of the mesocortical DA system by stress. Nature 1988, 263:242-243.
11. Gibson GE, Pusilnalli W, Blass JP Brain dysfunction in mild to moderate hypoxia. Am J Med 1981, 70:1247-1254.
12. Eidelman LA, Putterman D, Sprung CL The spectrum of septic encephalopathy. JAMA 1996, 275:470-473.
13. Barkham TM, Martin EC, Eykyn SJ Delay in the diagnosis of bacteraemic urinary tract infection in elderly patients. Age Aging 1996, 25:130-132.
14. Ludwig AM Principles of clinical psychiatry 1980, The Free Press, New York.
15. Adler LE, Bell J, Kirch D, et al. Psychosis associated with clonidine withdrawal. Am J Psychiatry 1982, 139:110-112.
16. Bastos PG, Sun X, Wagner DP, et al. Glasgow Coma Scale score in the evaluation of outcome in the intensive care unit: findings from the Acute Physiology and Chronic Health Evaluation III study. Crit Care Med 1993, 21:1459-1465.
17. Folstein MF, Folstein SE, McHugh PR "Mini-Mental State," a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
18. Snavely SR, Hodges GR The neurotoxicity of antibacterial agents. Ann Intern Med 1984, 101:92-104.
19. Cassem NH, Lake CR, Boyer WF Psychopharmacology in the ICU. The pharmacologic approach to the critically ill patient 1995, Williams & Wilkins, Baltimore. B. Chernow (Ed.).
20. Drugs that may cause psychiatric symptoms. Med Letter Drugs Ther 2002, 44:59-62.
21. Sommer BR, Wise LC, Kraemer HC Is dopamine administration possibly a risk factor for delirium?. Crit Care Med 2002, 30:1508-1511.
22. Shochet RB, Murray GB Neuropsychiatric toxicity of meperidine. J Intens Care Med 1988, 3:246-252.
23. Dubois MJ, Bergeron N, Dumont M, et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001, 27:1297-1304.
24. Sirois F Steroid psychosis: a review. Gen Hosp Psychiatry 2003, 25:27-33.
25. Stern TA Continuous infusion of physostigmine in anticholinergic delirium: case report. J Clin Psychiatry 1983, 44:463-464.
26. Shapiro BA Sedation for mechanically ventilated patients: back to basics please!. Crit Care Med 1994, 22:904-906.
27. Sos J, Cassem NH The intravenous use of haloperidol for acute delirium in intensive care settings. Psychic and neurological dysfunctions after open heart surgery 1980, George Thieme Verlag, Stuttgart. H. Speidel, G. Rodewald (Eds.).
28. Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987, 48:278-280.
29. Forsman A, Ohman R Pharmacokinetic studies on haloperidol in man. Curr Therap Res 1976, 10:319.
30. Adams F, Fernandez F, Andersson BS Emergency pharmacotherapy of delirium in the critically ill cancer patient: intravenous combination drug approach. Psychosomatics 1986, 27(suppl 1):33-37.
31. Tesar GE, Murray GB, Cassem NH Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985, 5:344-347.
32. Sanders KM, Stern TA, O'Gara PT, et al. Delirium after intra-aortic balloon pump therapy. Psychosomatics 1992, 33:35-41.
33. Fernandez F, Holmes VF, Adams F, et al. Treatment of severe, refractory agitation with a haloperidol drip. J Clin Psychiatry 1988, 49:239-241.
34. Metzger E, Friedman R Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharm 1993, 13:128-132.
35. Wilt JL, Minnema AM, Johnson RF, et al. Torsades de pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993, 119:391-394.
36. Hunt N, Stern TA The association between intravenous haloperidol and torsades de pointes: three cases and a literature review. Psychosomatics 1995, 36:541-549.
37. Di Salvo TG, O'Gara PT Torsades de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 1995, 18:285-290.
38. Zeifman CWE, Friedman B Torsades de pointes: potential consequence of intravenous haloperidol in the intensive care unit. Intensive Care World 1994, 11:109-112.
39. Day CP, James OFW, Butler TJ, et al. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993, 341:1423-1428.
40. Kao LW, Kirk MA, Evers SJ, et al. Droperidol, QT prolongation and sudden death: what is the evidence?. Ann Emerg Med 2003, 41:546-558.
41. Schwartz TL, Masand PS The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002, 43:171-174.
42. Fernandez F, Levy JK, Mansell PWA Management of delirium in terminally ill AIDS patients. Int J Psychiatr Med 1989, 19:165-172.
43. Breitbart W, Marotta RF, Call P AIDS and neuroleptic malignant syndrome. Lancet 1988, 2:1488-1489.
44. Caroff SN, Rosenberg H, Mann SC, et al. Neuroleptic malignant syndrome in the critical care unit. Crit Care Med 2002, 30:2609.
45. Fernandez F, Levy JK The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus: case reports. Gen Hasp Psychiatry 1993, 15:31-35.
46. Olmedo R, Hoffman RS Withdrawal syndromes. Emerg Med Clin N Am 2000, 18:237-288.
47. Barr J, Donner A Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin 1995, 11:827-847.
48. Cohen IL, Gallagher TJ, Pohlman AS, et al. Management of the agitated intensive care unit patient. Crit Care Med 2002, 30(1 suppl):S97-S123.
49. Hurford WE Sedation and paralysis during mechanical ventilation. Respir Care 2002, 47:334-347.
50. Higgins TL, Yared J-P, Estafanous FG, et al. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit Care Med 1994, 22:1415-1423.
51. Cohen D, Horiuchi K, Kemper M, et al. Modulating effects of propofol on metabolic and cardiopulmonary responses to stressful intensive care unit procedures. Crit Care Med 1996, 24:612-617.
52. Mirski MA, Muffelman B, Ulatowski JA, et al. Sedation for the critically ill neurologic patient. Crit Care Med 1995, 23:2038-2053.
53. Valenti JF, Anderson GL, Branson RD, et al. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994, 22:710-712.
54. Mirenda J Prolonged propofol sedation in the critical care unit. Crit Care Med 1995, 23:1304-1305.
55. El-Ebiary M, Torres A, Ramirez J, et al. Lipid deposition during the long-term infusion of propofol. Crit Care Med 1995, 23:1928-1930.
56. Turnage WS, Mangar D Sufentanil, midazolam, and atracurium admixture for sedation during mechanical circulatory assistance. Crit Care Med 1993, 21:1099-1100.
57. Riker RR, Fraser GL, Cox PM Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994, 22:433-440.
58. Thorens J-B, Kaelin RM, Jolliet P, et al. Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease. Crit Care Med 1995, 23:1807-1815.
59. Prezant DJ, Aldrich TK Intravenous droperidol for the treatment of status asthmaticus. Crit Care Med 1988, 16:96-97.
60. Klein RF, Kliner WA, Zipes DP, et al. Transfer from a coronary care unit: some adverse responses. Arch Intern Med 1968, 122:104-108.